Related references
Note: Only part of the references are listed.Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
Karen S. Aboody et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors
Ting Zhang et al.
STEM CELL RESEARCH & THERAPY (2013)
Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use
Marianne Z. Metz et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Suicide gene therapy in cancer: Where do we stand now?
Sonia Duarte et al.
CANCER LETTERS (2012)
Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis
Ruth S. Waterman et al.
PLOS ONE (2012)
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
Attilio Bondanza et al.
BLOOD (2011)
E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models
L. Garcia-Rodriguez et al.
GENE THERAPY (2011)
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
Fernanda I. Staquicini et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
In vivo MR tracking of therapeutic microglia to a human glioma model
Emeline J. Ribot et al.
NMR IN BIOMEDICINE (2011)
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
Ann H. Klopp et al.
STEM CELLS (2011)
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
B. Sangro et al.
CANCER GENE THERAPY (2010)
Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model
L-S Chen et al.
GENE THERAPY (2010)
Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population
Weiwei Hu et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2010)
Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors
Khaled Greish et al.
JOURNAL OF GENE MEDICINE (2010)
Prevention of intrahepatic metastasis of liver cancer by suicide gene therapy and chemokine ligand 2/monocyte chemoattractant protein-1 delivery in mice
Kaheita Kakinoki et al.
JOURNAL OF GENE MEDICINE (2010)
Advances in mesenchymal stem cell-mediated gene therapy for cancer
Roisin M. Dwyer et al.
STEM CELL RESEARCH & THERAPY (2010)
Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors
F. Xu et al.
CANCER GENE THERAPY (2009)
A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer
Wei Tang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1954
Prashant Patel et al.
MOLECULAR THERAPY (2009)
Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
Gabi U. Dachs et al.
MOLECULES (2009)
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
Shannon Kidd et al.
STEM CELLS (2009)
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment
Ann H. Klopp et al.
CANCER RESEARCH (2007)
Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma
Ning Li et al.
CLINICAL CANCER RESEARCH (2007)
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy
Lucia Kucerova et al.
CANCER RESEARCH (2007)
Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
Suicide genes for cancer therapy
Daniel Portsmouth et al.
MOLECULAR ASPECTS OF MEDICINE (2007)
Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy
C. Richard et al.
CANCER GENE THERAPY (2007)
Activation of oxazaphosphorines by cytochrome P450: Application to gene-directed enzyme prodrug therapy for cancer
P Roy et al.
TOXICOLOGY IN VITRO (2006)
Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors
H Sato et al.
CANCER GENE THERAPY (2005)
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma
JP Braybrooke et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells
U Fischer et al.
ONCOGENE (2005)
Apoptosis induction with 5-fluorocytosine/cytosine deaminase gene therapy for human malignant glioma cells mediated by adenovirus
K Kurozumi et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Targeting gene therapy for prostate cancer
NJ Maitland et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies
DA Hamstra et al.
MOLECULAR THERAPY (2004)
Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery
JW Wei et al.
CANCER CELL (2004)
Virus-directed enzyme prodrug therapy: Intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer
DH Palmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma
J Voges et al.
ANNALS OF NEUROLOGY (2003)
Pilot trial of genetically modified, attenuated Salmonella expressing the E-coli cytosine deaminase gene in refractory cancer patients
J Nemunaitis et al.
CANCER GENE THERAPY (2003)
Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion
M Herraiz et al.
HUMAN GENE THERAPY (2003)
Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer
H Kubo et al.
HUMAN GENE THERAPY (2003)
Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation
MT Tomicic et al.
ONCOGENE (2002)
Nitroreductase-based GDEPT
WA Denny
CURRENT PHARMACEUTICAL DESIGN (2002)
Molecular approaches to chemo-radiotherapy
B Marples et al.
EUROPEAN JOURNAL OF CANCER (2002)
Direct retroviral delivery of human cytochrome P4502B6 for gene-directed enzyme prodrug therapy of cancer
O Kan et al.
CANCER GENE THERAPY (2001)
Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide
P Karle et al.
CANCER GENE THERAPY (2001)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay et al.
NATURE MEDICINE (2001)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine
F Koyama et al.
CANCER GENE THERAPY (2000)
Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy
Y Hasegawa et al.
CANCER GENE THERAPY (2000)
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis
M Bentires-Alj et al.
CANCER GENE THERAPY (2000)
Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine
Y Adachi et al.
HUMAN GENE THERAPY (2000)
In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus
T Ichikawa et al.
CANCER GENE THERAPY (2000)
Share Paper
